Printer Friendly

BIOSOURCE INTERNATIONAL REPORTS EARNINGS, ANNOUNCES NEW BOARD MEMBER

 CAMARILLO, Calif., Aug. 16 /PRNewswire/ -- BioSource International Inc. (NASDAQ: BIOI) today announced its second quarter 1993 earnings. For the period (April 1-June 30), company revenues were $1,351,429 and earnings were $40,103. For the same period in 1992, consolidated results of predecessor companies to BioSource International, on a pro forma consolidated basis, were $1.05 million in revenues, with earnings of $2,481. For the six month period (Jan. 1-June 30), revenues were $2.61 million and earnings were $200,319; compared to consolidated pro forma results of $2.03 million revenue and $7,890 in earnings for the 1992 period.
 The company also announced the additional of a new member to the board of directors, effective Aug. 8, fulfilling a requirement of the consolidation agreement that formed BioSource International. The consolidation of BioSource and Tago Inc. was completed on May 19, 1993.
 Discussion of Earnings
 "As an integrated biotechnology company, we now have an appropriate mix of both internally developed and licensed products in our catalog for the biomedical research and diagnostic markets we serve," said James Chamberlain, president and chief executive officer of BioSource International. "This was a principal goal of the consolidation of BioSource and Tago and this second consecutive profitable quarter since the merger validates our strategy. We believe the period of losses recorded by the two separate companies is over and that we are now well positioned for consistent, profitable growth."
 Chamberlain noted that net earnings for the quarter were limited by a combination of one-time charges related to the consolidation, higher sales and marketing costs, and increased expenditures on research and development.
 "We completed and mailed our new combined products catalog, describing nearly 600 stocking items, and nearly tripled our spending on paid advertising to support new products that became available in the quarter," said Chamberlain. "Additionally, we increased spending on product research by 65 percent, with particular emphasis on development of new ELISA assay kits. The advertising spending is already contributing to higher sales, and we expect that additional new products will be ready by the fourth quarter of this year."
 Addition to Board
 The new member of the board, John Power of Vacaville, Calif., was a principal shareholder in Tago Inc. prior to the consolidation of the two companies. As part of the agreement in which the companies were consolidated, the shareholders of Tago Inc. were authorized to name two directors to the board, and Power was designated as one of these board members. Power is the president of the Redwood MicroCap Fund Inc., a mutual fund specializing in companies with small market capitalizations. He also sits on the board of directors of Plants For Tomorrow, an environmental services firm in West Palm Beach, Fla.
 "BioSource is an ideal example of the type of undiscovered, emerging growth company I enjoy working with," said Power. "With their extensive and growing product line, solid market coverage and experienced senior management, I see significant potential for long-term, profitable growth. I am very pleased to be a member of the board and look forward to helping the company as it implements its strategic plan."
 NOTE: BioSource International Inc. is a Camarillo-based supplier of immunological reagents and test kits used in biomedical research. The company offers more than 600 products, including recombinant proteins, monoclonal antibodies and ELISA assay kits to a variety of antigens. Incorporated in 1989, the company was listed on Nasdaq in May 1993, after completing the acquisition of Tago Inc. Combined FY 1992 revenues of the merged company were $4 million. First quarter 1993 (Jan. 1-March 31) revenues were $1.26 million, and the company reported net income of $0.16 million.
 BIOSOURCE INTERNATIONAL INC.


Unaudited Earnings: Second Quarter and Half-Year Ending June 30, 1993
 Three Months Ending Six Months Ending
 June 30: 1993 1992(A) 1993 1992(A)
 Sales $1,351,429 $1,057,428 $2,614,732 $2,033,410
 Net Income $ 40,103 $ 2,481 $ 200,319 $ 7,890
 Net Income/Share $ 0.011 $ 0.001 $ 0.052 $ 0.003
 Weighted Average
 Number of Shares 3,527,313 2,973,233 3,851,981 3,066,382
 (A) Stated 1992 results are a pro forma combination of actual 1992 results of BioSource Industries Inc. and Tago Inc., the predecessor companies to BioSource International.
 -0- 8/16/93
 /CONTACT: James Chamberlain, president, or Anna Anderson, treasurer, of BioSource International, 805-987-0086; or Matthew Schmidt of FS Communications, 415-691-1488, for BioSource International/
 (BIOI)


CO: BioSource International Inc. ST: California IN: MTC SU: ERN PER

TM-LH -- SJ005 -- 3011 08/16/93 11:04 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 16, 1993
Words:761
Previous Article:DOW JONES NEWS HEADLINES, SPORTS NEWS, UPDATED TREASURY BOND DATA AND MORE NOW AVAILABLE ON SIGNAL
Next Article:PROTEON ANNOUNCES SUPPORT FOR IBM'S LAN NETWORK MANAGER, RELEASE OF ONEVIEW/PC, AND COMMITMENT TO OPENVIEW, NETVIEW/6000 PLATFORMS
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters